The PI3K and Akt inhibitors abolished the cigarette smoke-mediated luciferase activity of NF-κB, indicating that the PI3K, Akt-activating NF-κB mediate cigarette smoke-induced promotion of IL-6 synthesis and cell motility in human lung cancer. Here, AKT1 is linked to lung cancer.